Vergoeding 2019-2023 voor ATC-subgroep B02BX : Overige systemische haemostatica
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| B02BX04 Romiplostim (Nplate ®) | 8.022.900 | 9.474.700 | 11.000.300 | 12.329.500 | 13.147.300 |
| B02BX05 Eltrombopag (Revolade ®) | 9.773.600 | 11.898.100 | 13.246.000 | 16.713.100 | 19.156.000 |
| B02BX08 Avatrombopag (Doptelet ®) | . | . | 10.693 | 245.210 | 1.083.500 |
| B02BX09 Fostamatinib (Tavlesse ®) | . | . | . | . | 290.120 |
| Totaal | 17.796.500 | 21.372.800 | 24.256.993 | 29.287.810 | 33.676.920 |